Financial Interest Index
As a provider accredited by the Accreditation council for Continuing Medical Education, ASCRS must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an activity designated for CME credit must disclose any financial interest or relationship with an ineligible company within the past 24 months that produces, markets, sells, resells, or distributes ophthalmic products/devices/drugs or services used on or by patients that are discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, et.
The intent of this disclosure is not to disqualify anyone from participating, but to provide the program committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index provides information to attendees, so they can make their own judgement regarding the interest or relationship and the materials presented. A complete listing of relations disclosed, and their corresponding codes are below.
Session I: Complex Cornea Cases
Marjan Farid, MD Is a consultant for Alcon, Allergan, Bausch and Lomb, and Zeiss.
Francis Mah, MD is a consultant for Alcon, Abbvie, and Bausch and Lomb. He receives lecture fees from Bausch and Lomb.
W. Barry Lee, MD Receives lecture fees from Alcon and Bausch and Lomb. He receives research and grant support from Aurion Biotech.
Naveen Rao, MD is a consultant for Glaukos.
Dean Ouano, MD has no relevant financial relationships.
Helen Wu, MD is a consultant for Bruder and Dompe.
Amy Lin, MD has no relevant financial relationships.
Carol Karp, MD is a consultant and equity owner/investor in Interfeen Biologics. She has a patent/royalty in PCT/US2022/029842
Elisabeth Cohen, MD has no relevant financial relationships.
William Trattler, MD is a consultant for Alcon, Allergan, Azura, Bausch and Lomb, Glaukos and Zeiss.
Michael Raizman, MD is a consultant and investor in Glaukos.
Deborah Jacobs, MD Is a consultant and inventors in TECLens, Inc.
Session II: Keratoplasty- Now and What’s Coming
Marjan Farid, MD has no relevant financial relationships.
Francis Mah, MD is a consultant for and receives lecture fees from Dompe and Santen.
Brandon Ayres, MD Is a consultant for Dompe.
Julie Schallhorn, MD has no relevant financial relationships.
Sanjay Patel, MD is a consultant for Santen, Inc. and Design Therapeutics. He receives a patent/royalty from Santen, Inc., Design Therapeutics, Inc., and Trefoil.
Jennifer Rose-Nussbaumer, MD has no relevant financial relationships.
Deepinder Dhaliwal, MD is a consultant for Trefoil.
Ula Jurkunas, MD has no relevant financial relationships.
Sadeer Hannush, MD has no relevant financial relationships.
Kanwal “Ken” Nischal, MD has no relevant financial relationships.
Parag Parekh, MD has no relevant financial relationships.
Session III: Anterior Segment and Cornea Surgical Video Roundup
Marjan Farid, MD is a consultant for CorneaGen.
Francis Mah, MD has no relevant financial relationships.
Winston Chamberlain, MD has no relevant financial relationships.
Leela Raju, MD has no relevant financial relationships.
David Rootman, MD has no relevant financial relationships.
Kavitha Sivaraman, MD has no relevant financial relationships.
Jessica Chen, MD has no relevant financial relationships.
Enrica Sarnicola, MD has no relevant financial relationships.
Sabrina Muktar, MD has no relevant financial relationships.
Simon Fung, MD has no relevant financial relationships.
Session IV: The Ocular Surface
Marjan Farid, MD is a consultant for Alcon, Bausch and Lomb and Johnson and Johnson Vision.
Francis Mah, MD is a consultant for Alcon, Azura, Bausch and Lomb, Johnson and Johnson Vision, and Sun Pharma. He receives lecture fees from Bausch and Lomb, Johnson and Johnson Vision and Sun Pharma. He receives research/grant support from Sight Sciences.
Sumit “Sam” Garg, MD Is a consultant for Glaukos and Johnson and Johnson Vision.
Zachary Zavodni, MD has no relevant financial relationships.
Clara Chan, MD is a consultant for Aurion Biotech and Santen. She receives lecture fees from Santen. She receives research/grant support from Corneat.
Albert Cheung, MD Has no relevant financial relationships.
Sarah Nehls, MD has no relevant financial relationships.
Saama Sabeti, MD has no relevant financial relationships.
Mitchell Weikert, MD is a consultant for Alcon and Carl Zeiss Meditec.
Mina Farahani, MD Is a consultant for Sight Sciences. She receives lecture fees from Sight Sciences.
Eric Donnenfeld, MD is a consultant for Allegro, Aurion Biotech, Glaukos, Kala and Lacripen. He is an investor in Aurion Biotech, Avedro/Glaukos, and Lacripen.
Carrie Braden, ASCRS Staff, have no financial interests.
All of the relevant financial relationships for these individuals have been mitigated.
